Quick Answer
Cell Source, Inc. reported Net Income Loss of -$5.32 million for the year ending 2023.
- Cell Source, Inc. showed a decrease of -3.0% in Net Income Loss from 2022 to 2023.
- This data is from Cell Source, Inc.'s annual report (Form 10-K), filed with the SEC on June 24, 2024.
- XBRL data for this metric is available from 2013 to 2023 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2013 to 2023), Cell Source, Inc.'s Net Income Loss has declined by 198.3%.
- Historical annual values: Fiscal year 2023: -$5.32 million | Fiscal year 2022: -$5.17 million | Fiscal year 2021: -$5.47 million | Fiscal year 2020: -$4.56 million | Fiscal year 2019: -$4.48 million | Fiscal year 2018: -$2.12 million | Fiscal year 2017: -$3.08 million | Fiscal year 2016: -$967.8 thousand | Fiscal year 2015: -$2.50 million | Fiscal year 2014: -$4.06 million | Fiscal year 2013: -$1.78 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: